1/21/11 Contest Update
Biotechs, especially small-caps, had some wild swings for the 4-day trading week but the Bears were pushing harder. At Friday’s close, the Nasdaq Biotech Index was up .68% YTD (vs. up 3.22% YTD a week ago) and the Contest median was up .96% YTD (vs. up 4.49% YTD a week ago). The Nasdaq Composite Index was up 1.38% YTD (vs. up 3.86% YTD a week ago).
RRGE’s portfolio (up 18.19% YTD) held on to the lead, with GENE’s portfolio (up 17.22% YTD) and PGO’s portfolio (up 12.49% YTD) taking second and third place. PGO’s portfolio was the sole holder (with a 5% allocation) of MSHL, the week’s best-performing biotech with an amazing 176% gain.
At Friday's close, 24 of the 38 Contest portfolios were in the black with 20 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a wonderful weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
1/21/11
Rank Name Profit/Loss
1 RRGE 18,190
2 GENE 17,218
3 PGO 12,488
4 RKRW 10,305
5 ROBERT 9,429
6 NIGEL 9,066
7 BULBA 7,071
8 CRAZYP 6,718
9 MCBIO 4,731
10 WILDER 4,703
Week's Top 5 Gainers
Symbol Symbol 12/31 % change
MSHL 1.05 2.90 175.67%
ICGN 2.00 2.49 24.50%
ARIA 5.25 6.40 21.90%
NRGX.OB 0.81 0.93 14.81%
GENT 8.10 9.18 13.33%
Week's Top 5 Losers
Symbol Symbol 12/31 % change
MRNA 1.60 1.24 -22.50%
VVUS 11.20 8.74 -21.96%
DEPO 7.12 5.81 -18.40%
MITI 7.90 6.53 -17.34%
AEGR 14.22 11.76 -17.30% |
